🤖 DIAGNOS Receives Saudi FDA Medical Device License
Published by OOPSONLINE.IN · Source: The Manila Times · 1 min read · · Updated
What actually happened
BROSSARD, Quebec, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. ('DIAGNOS” or the 'Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that today, August 13, 2026, it has received Medical Device Marketing Authorization for the CARA System (CARA) from the Saudi Food and Drug Authority (SFDA).
Key points
- 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc.
- ('DIAGNOS” or the 'Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that today, August 13, 2026, it has received Medical Device Marketing Authorization for the CARA System (CARA) from the Saudi Food and Drug Authority (SFDA).
Summary based on data provided by The Manila Times. Full article available at the original publisher.
- #ai
- #diagnos
- #receives